Skip to main content
CRBG
NYSE Finance

Corebridge Q3 Call: $100M of Merger Synergies Identified, Year-End Close Targeted

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$35.75
Mkt Cap
$15.932B
52W Low
$22.19
52W High
$36.56
52W Position info
61% above low
Off High info
2.2% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

CRBG sits 61% above its 52-week low of $22.19 on elevated volume (1.8× avg).

Summary

Corebridge's Q3 call transcript adds merger detail beyond the already-reported results: over $100 million of run-rate expense savings identified, more than $1.5 billion of PRT deals set to close in Q4, and a year-end merger close still targeted.


Key Events · Earnings and Guidance · CRBG

  • Q3 Operating EPS $1.22, Up 27%

    Operating EPS rose 27% year-over-year to $1.22, a penny below the $1.24 consensus, while revenue fell 20% to $4.50 billion. Adjusted ROE was 12.1%, or 13.4% on a run-rate basis.

  • Over $100M of Merger Synergies Identified

    Management has identified over $100 million of run-rate expense savings to be realized in the first half of 2027, toward a $150 million 2027 target and at least $500 million by the end of 2028.

  • $1.5B of PRT Deals Set for Q4

    Q3 PRT volume was modest at $156 million, but Corebridge has already been selected as counterparty on over $1.5 billion of PRT transactions expected to close in the fourth quarter.

  • Year-End Merger Close Targeted

    All required federal approvals for the Equitable merger are received; state and international approvals remain outstanding, with the company still guiding to a year-end close and new Board members already selected.


Analysis · CRBG · Finance

With the Q3 numbers already out on November 2, the transcript's value lies in the forward detail. Management has identified over $100 million of run-rate expense savings to be realized in the first half of 2027, putting the company on the way to a $150 million 2027 target and at least $500 million by the end of 2028. It also disclosed that it has been selected as counterparty on more than $1.5 billion of pension risk transfer deals expected to close in the fourth quarter, following a soft $156 million of PRT volume in Q3. All federal approvals for the Equitable merger are in hand, with state and international approvals still pending and a year-end close still the target. Against that, Q3 operating EPS of $1.22 missed the $1.24 consensus by a penny and revenue fell 20% to $4.50 billion, so the quarter itself was not a beat.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRBG was trading at $35.75 on NYSE in the Finance sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $22.19 to $36.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRBG - Latest Insights

CRBG
Nov 03, 2026, 11:48 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $35.74
Real-time Price: $34.64 info
Change: -$1.11 (-3%) info
Market Cap: $15.184B info
CRBG
Nov 03, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.74
Real-time Price: $34.64 info
Change: -$1.11 (-3%) info
Market Cap: $15.184B info
CRBG
Nov 02, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.04
Real-time Price: $34.64 info
Change: -$0.405 (-1%) info
Market Cap: $15.184B info
CRBG
Nov 02, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $35.04
Real-time Price: $34.64 info
Change: -$0.405 (-1%) info
Market Cap: $15.184B info
CRBG
Oct 27, 2026, 4:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $35.39
Real-time Price: $34.64 info
Change: -$0.755 (-2%) info
Market Cap: $15.184B info